Pet Veterinary Drug refers to a drug used in the diagnosis, cure, mitigation, treatment or prevention of diseases in pets.
The global pet veterinary drug market is divided into drugs and biological agents and vaccines according to drugs. According to the ingredients, it is divided into anti-infectives, anti-inflammatory drugs, parasiticides, analgesics and sedatives. Due to the significant growth of the global healthcare industry, global demand for pet veterinary drugs is increasing.
According to this study, over the next five years the Pet Veterinary Drug market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Pet Veterinary Drug business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Pet Veterinary Drug market by product type, application, key manufacturers and key regions and countries.
This study considers the Pet Veterinary Drug value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Anti-Infectives
Anti-Inflammatory
Parasiticides
Analgesics
Sedatives
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Veterinary Hospitals
Veterinary Clinics
Drug Stores
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Boehringer Ingelheim International GmbH
Zoetis Animal Healthcare
Bayer AG
Merck Animal Health
Elanco Animal Health Inc.
Virbac Group
Ceva
Dechra Pharmaceuticals Plc
Vetoquinol
Orion Corporation
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Pet Veterinary Drug consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Pet Veterinary Drug market by identifying its various subsegments.
Focuses on the key global Pet Veterinary Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Pet Veterinary Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Pet Veterinary Drug submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Summary:
Get latest Market Research Reports on Pet Veterinary Drug. Industry analysis & Market Report on Pet Veterinary Drug is a syndicated market report, published as Global Pet Veterinary Drug Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Pet Veterinary Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.